Ryan Braun’s name discovered in the Biogenesis records

68 Comments

From Jeff Passan and Tim Brown of Yahoo! Sports:

Milwaukee Brewers star Ryan Braun’s name is in records of the Miami-area clinic alleged to have distributed performance-enhancing drugs to a rash of baseball players, and Major League Baseball will investigate the link to the former MVP who tested positive for illegal synthetic testosterone during the 2011 postseason.

Braun was cleared of that 2011 positive test due to what was perceived to be an error in the handling of his urine sample. His name is not listed next to any specific PED transactions in the Biogenesis records, but Major League Baseball will investigate the matter in the hope of learning about the outfielder’s exact level of involvement.

Yankees catcher Francisco Cervelli and Orioles third baseman Danny Valencia were also discovered in the records at the Biogenesis clinic but, like Braun, were not listed in connection with a specific PED.

**********************

UPDATE, 11:21 PM: Braun says in a written statement that he used Bosch for consulting in his successful PED appeal and that he has “nothing to hide” —

“During the course of preparing for my successful appeal last year, my attorneys, who were previously familiar with Tony Bosch, used him as a consultant. More specifically, he answered questions about T/E ratio and possibilities of tampering with samples. There was a dispute over compensation for Bosch’s work, which is why my lawyer and I are listed under ‘moneys owed’ and not on any other list. I have nothing to hide and have never had any other relationship with Bosch. I will fully cooperate with any inquiry into this matter.”

Report: Nathan Eovaldi drawing interest from at least nine teams

Nathan Eovaldi
Getty Images
3 Comments

Former Red Sox right-hander Nathan Eovaldi is up for grabs this offseason, and Nick Cafardo of the Boston Globe says that as many as nine suitors are interested in bringing the righty aboard. While the Red Sox are eager to retain Eovaldi’s services after his lights-out performance during their recent postseason run, they’ll have to contend with the Brewers, Phillies, Braves, White Sox, Padres, Blue Jays, Giants, and Angels — all of whom are reportedly positioned to offer something for the starter this winter.

It wasn’t all smooth sailing for the 28-year-old in 2018, however. After losing his 2017 season to Tommy John surgery, he underwent an additional procedure to remove loose bodies from his right elbow in March and didn’t make his first appearance until the end of May. He was flipped for lefty reliever Jalen Beeks just prior to the trade deadline and finished his season with a combined 6-7 record in 21 starts, a 3.81 ERA, 1.6 BB/9, and 8.2 SO/9 through 111 innings.

Despite his numerous health issues over the last few years, Eovaldi raised his stock in October after becoming a major contributor during the Red Sox’ championship run. He contributed two quality starts in the ALDS and ALCS and returned in Games 1-3 of the World Series with three lights-out performances in relief — including a six-inning effort in the 18-inning marathon that was Game 3.

A frontrunner has yet to emerge for the righty this offseason, but Cafardo points out that the nine teams listed so far might just be the tip of the iceberg. Still, he won’t be the most sought-after starter on the market, as former Diamondbacks southpaw Patrick Corbin is expected to command an even bigger payday following his career-best 6.0-fWAR performance in 2018.